SCHEMBL23749581

SCHEMBL23749581

CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc3cc(OCCCN4CCS(=O)(=O)CC4)c4c(c23)OCCO4)c(F)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 7/20 0.61
MST1R Q04912 11/20 0.59
AXL P30530 6/20 0.57
TYRO3 Q06418 3/20 0.57
MERTK Q12866 3/20 0.57
RET P07949 2/20 0.57
PLK4 O00444 1/20 0.57
ABL1 P00519 1/20 0.57
NTRK1 P04629 1/20 0.57
LCK P06239 1/20 0.57
KIT P10721 1/20 0.57
PDGFRA P16234 1/20 0.57
PRKACA P17612 1/20 0.57
KDR P35968 1/20 0.57
FLT3 P36888 1/20 0.57
ABL2 P42684 1/20 0.57
FRK P42685 1/20 0.57
DDR1 Q08345 1/20 0.57
PDE4D Q08499 1/20 0.57
MAP4K2 Q12851 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31441121 1.00 MET (0.61) METMST1RAXLTYRO3MERTK
SCHEMBL23749580 0.96 MET (0.62) METMST1RAXLTYRO3MERTK
SCHEMBL23749292 0.95 MET (0.63) METMST1RAXLTYRO3MERTK
SCHEMBL23749273 0.94 MET (0.64) METMST1RAXLTYRO3MERTK
SCHEMBL23749511 0.94 MST1R (0.66) METMST1RAXLTYRO3MERTK
SCHEMBL23749544 0.94 MET (0.63) METMST1RAXLTYRO3MERTK
SCHEMBL23749520 0.92 MET (0.61) METMST1RAXLTYRO3MERTK
SCHEMBL23749411 0.92 MET (0.61) METMST1RAXLTYRO3MERTK
SCHEMBL23749514 0.92 MET (0.61) METMST1RAXLTYRO3MERTK
SCHEMBL31441119 0.92 MET (0.61) METMST1RAXLTYRO3MERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-01-06 US disclosed
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-01-06 US disclosed
EP-3865487-A1 AROMATIC RING-LINKED DIOXANE-QUINAZOLINE OR -QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2021-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF MERTK, AXL, TYRO3 MET 14/4885MST1R 111/4885AXL 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.